Cedrus libani

Cedrus libani (Cedar of Lebanon): A Comprehensive Reference

1. Identity and Botanical Description

Scientific name: Cedrus libani A. Rich. (also encountered in older literature as Cedrus libanotica). It belongs to the family Pinaceae, genus Cedrus, and is one of only four accepted species of "true cedars." Commonly known as Lebanon cedar, it is a tree species significant for its historical, cultural, aesthetic, scientific, and economic value, primarily found in the Taurus Mountains of Turkey and historically prevalent in Syria and Lebanon.

Cedrus is a vital member of the Pinaceae family, with elegant, decorative, evergreen, high, and monoecious conifer members that grow widely on mountains, particularly in the South, Southeast Mediterranean, and Western Himalaya. One of the four species, it is currently found in only a few locations around the Eastern Mediterranean, and is a biologically significant species with one of the earliest ethnobotanical values in the history of mankind, still attracting attention due to the ethnobotanical uses prevalent in its range.

Cedrus libani can reach 40 m (130 ft) in height, with a massive monopodial columnar trunk. The leaves are needle-like, arranged in spirals and concentrated at the proximal end of the long shoots, and in clusters of 15–35 on the short shoots; they are 5 to 35 mm long and 1 to 1.5 mm wide, rhombic in cross-section, and vary from light green to glaucous green with stomatal bands on all four sides.

It still grows in sparse stands in the mountains of Syria, Lebanon, and Turkey, between 1,300 and 2,100 m in altitude, preferring full sun and calciferous soil. Heavy cutting, burning, and goat grazing for the past 5,000 years have left only small populations in Syria and Lebanon.

Common Names and Synonyms

• Cedar of Lebanon; Lebanon Cedar (English)
• Cèdre du Liban (French)
• Lübnan sediri or Toros sediri (Turkish, denoting the Taurus cedar subspecies)
• Arz al-Rabb (Arabic: "Cedar of God")

Plant Parts Used and Preparations

Multiple plant organs are used in traditional and scientific contexts. Several compounds have been isolated from needles, heartwood, stem wood, stem bark, oleoresin, and oil extracted from needles and wood. The principal preparations documented in scientific literature include:

• Essential oils (EOs): Obtained by hydro-distillation or steam distillation from heartwood, needles/leaves, roots, and cones.
• Resin / oleoresin: Exudate collected from the bark or wood.
• Tar (katran): Pyrolytic product traditionally extracted from the wood, particularly in the Antalya region of Turkey. Tar is traditionally extracted from cedar trees in the Antalya region of Türkiye.
• Ethanol and chloroform extracts: Used in laboratory and pharmacological studies from seeds, leaves, and cones.
• Hexane (lipophilic) extracts: Applied for the isolation of terpenoid-rich oil fractions from heartwood.

2. Traditional and Historical Use

Ancient Civilizations

The cultural history of Cedrus libani is among the most extensive of any tree species. C. libani has been used by humans since ancient times; records from the ancient kingdom of Sumer tell of the warrior-king Gilgamesh building his city out of cedar wood. About 4,600 years ago, King Snefru of the Fourth Dynasty of ancient Egypt used 40 shiploads of cedar timber for shipbuilding and for the heavy doors of the king's palace, and it was undoubtedly used in similar ways before this earliest written record.

Historically, the ancient Phoenicians used cedar wood for shipbuilding and traded cedar trees with Ancient Egypt, Ancient Greece, Anatolians, Iberians, Punics, Sicilians, Romans, and Ancient Iraq. The cedar is mentioned often in the Old Testament of the Bible; for example, the First Temple of Solomon was built of it.

Cedar sap was believed to have been used in the preservation of corpses in Egypt. The sap was also used for tooth pain. These uses align with accounts in the peer-reviewed literature, which indicate that C. libani was traditionally used to cure a wide range of illnesses, including inflammatory and respiratory conditions, as well as to relieve toothache pain.

Conservation and Legal Protections in Antiquity

The cedar also seems to have been the first species to receive any form of conservation protection: the Roman emperor Hadrian created an imperial forest by fencing off a Cedrus libani woodland and marking its perimeter with inscribed boundary stones, in order to conserve those woods.

Traditional Medicinal Uses in Lebanon and the Near East

Cedrus libani is widely used as traditional medicine in Lebanon for the treatment of different infectious diseases. Traditional healers in the Levant, Anatolia, and neighboring regions employed various plant parts for therapeutic purposes:

• Resin/oleoresin: Applied to wounds as an antiseptic, and taken internally or inhaled as an expectorant for respiratory conditions including coughs and bronchitis.
• Wood and bark: Resins from roots and stems were reported for antimicrobial purposes. Antimicrobial activity of the resins obtained from the roots and stems of Cedrus libani and Abies cilicica was documented in ethnopharmacological literature.
• Tar (katran): Local people in Antalya province of Türkiye were observed to spray an undiluted or diluted liquid called 'katran,' extracted from the wood of a cedar tree, on domestic animals such as goats, sheep, and dogs — a practice representing the traditional veterinary use of the tar as an antiparasitic.
• Anti-rheumatic and anti-neuralgic use: Plants including C. libani were documented as remedies antirheumatic and antineuralgic in the traditional medicine of Lebanon (El-Beyrouthy et al., Journal of Ethnopharmacology, 2008).

The antioxidant activity of the ethanolic extracts of Cedrus libani leaves has been noted in the literature, indicating the potential anti-inflammatory and analgesic properties of flavonoids and tannins.

3. Key Constituents and Active Compounds

3.1 Heartwood and Wood Essential Oil

The major components of C. libani wood essential oil are α-himachalene (7.1–12.8%), γ-himachalene (4.4–9.1%), β-himachalene (8.1–38.2%), himachalol (1.2–43.1%), and (E)-α-atlantone (0.8–19.7%). These ranges reflect variation by geographic origin (Lebanon vs. Turkey) and extraction method. Among the 14 components identified in heartwood essential oil, α-, β-, γ-isomers of himachalene and himachalol together constituted 75% of the composition, with smaller amounts of the (E) and (Z) isomers of α-, β- and γ-atlantone also present.

In a landmark study on heartwood hexane extract, the tree heartwood was extracted using hexane to produce C. libani oil extract (CLOE), and GC-MS analysis identified up to 30 compounds, with 2-himachalen-7-ol (7-HC) as the most abundant at 40%.

Water and steam-distilled essential oils from wood and roots of Taurus Cedar obtained from Antalya and Icel (Tarsus) provinces yielded 37 characterized components representing 90–93% of the oils, with himachalenes (α-, β-, and γ-) constituting 58.6% of the oils. Novel sesquiterpenes identified from this source for the first time included cis- and trans-10,11-dihydroatlantones, cis- and trans-β-atlantones, 8,9-dehydroneoisolongifolene, longipinene, α-ylangene, camphor, sativene, α-guijunene, longifolene, α-cedrene, α-calacorene, oxidohimachalene, isohimachalone, nerolidol, longiborneol, cadalene, limonene, and terpinolene.

3.2 Leaf (Needle) Essential Oil

The principal constituents of the needle oil were identified as terpenoids: α-pinene, β-pinene, myrcene, α-myrcene, limonene-α, β-caryophyllene, β-copaene, α-himachalene, β-humulene, γ-muurolene, β-himachalene, germacrene D, α-muurolene, δ-cadinene, γ-amorphene, dl-limonene, trans-caryophyllene, linalyl propionate, dodecanoic acid, caryophyllene oxide, and 1-dodecanol.

The leaves ethanol extract was characterized by a high content of germacrene D (29.40%). The essential oil isolated from Cedrus libani leaves may bear potential for drug development due to its high concentrations of germacrene D and β-caryophyllene.

3.3 Cone Essential Oil

The ethanol extract obtained from cones essentially contained α-pinene (51.0%) and β-myrcene (13.0%). Monoterpenes predominate in the cone fraction, contrasting with the sesquiterpene-rich profile of the heartwood.

3.4 Seed Extracts

Seeds of C. libani have been extracted through ultrasound-assisted maceration and evaluated for antiproliferative and erythroid differentiation properties, with preliminary chemical compositions performed to identify the chemical classes mainly responsible for bioactivity. Chloroform extracts evidenced the predominant presence of terpenes; the monoterpenes α- and β-pinene were the most abundant (34.42 ± 1.22% and 33.28 ± 1.08%, respectively), and are most probably directly involved in antiproliferative activity against K562 cells (IC₅₀ = 69.20 ± 1.69 μg/mL).

3.5 Tar Composition

The composition of the tar is primarily characterized by a diverse mixture of terpenes, with β-himachalene (29.16%), α-atlantone (28.7%), ar-turmerone (8.82%), longifolene-(V4) (6.66%), α-himachalene (5.28%), and β-turmerone (5.12%) emerging as the predominant constituents.

3.6 Non-Terpenoid Compounds

Phytochemical analysis of oils extracted from several Cedrus species revealed that steroids, procyanidins, and terpenoids are the major constituents. In addition to terpenoids, the genus is known to contain flavonoid and diterpenoid compounds. Terpene acids have also been characterized from C. libani, with novel bisabolane-type sesquiterpene acids and a dihydroxyflavone methyl ether reported in older phytochemical literature from ScienceDirect (Phytochemistry, 1988). Phytochemical studies have reported 105 chemical constituents from different parts of the plant, most belonging to the class of terpenoids and flavonoids.

4. Established and Proposed Mechanisms of Action

Anti-inflammatory Mechanisms

Extracts from Cedrus libani have been reported to exert in vitro and in vivo anti-inflammatory action by inhibiting COX-2/TNF-α/NF-κB activation, repressing the lipoxygenase activity, and preventing linoleic acid and lipid peroxidation. More specifically, the isolated compound 2-himachalen-7-ol (7-HC) has been studied mechanistically: 7-HC exhibited significant anti-inflammatory effect in formalin-induced paw edema in rats, and Western blot analysis revealed that 7-HC displayed dose-dependent inhibition of LPS-induced COX-2 protein expression in isolated rat monocytes.

2-himachalen-7-ol has been shown to mediate immunomodulatory effects by inhibiting induced COX-2 expression in LPS-treated immune and cancer cells.

Anticancer Mechanisms

The wood oil of C. libani was shown to possess potent antitumor effect against K562 human chronic myelogenous leukemia cells, as well as against multi-drug resistant leukemia cells. Additionally, the C. libani wood oil induced erythroid differentiation at the terminal phase which is known to stimulate the expression of fetal globin genes. The studies demonstrate that 7-HC possesses promising anticancer and anti-inflammatory activities, and may serve as a lead molecule in cancer therapy.

Antimicrobial Mechanisms

Phytochemical analysis of oils extracted from several Cedrus species revealed that steroids, procyanidins, and terpenoids are the major constituents. These phytochemicals have been shown to possess a wide range of biological activities, such as anticancer, anti-inflammatory, and antimicrobial effects. The sesquiterpene and monoterpene fractions of the essential oils are considered principal contributors to antimicrobial activity, a property widely attributed to membrane-disrupting terpenes across Pinaceae species.

Acaricidal / Insecticidal Mechanisms

The essential oil obtained from cedar wood chips rich in himachalenes and atlantones showed promising larvicidal activity, and himachalenes and atlantones account for more than 63% of the C. libani tar content. The predominance of these bioactive sesquiterpenes is considered the mechanistic basis for the tar's antiparasitic effects.

5. Scientific Evidence by Area of Use

5.1 Anticancer Activity

Evidence base: In vitro and in vivo (rodent) studies only. No human clinical trials identified.

The most detailed study on anticancer activity of a C. libani-derived compound is a 2019 publication in Scientific Reports (Nature Publishing Group) by Elias et al. The tree heartwood was extracted using hexane to produce C. libani oil extract (CLOE) as a dark oil; GC-MS analysis identified up to 30 compounds, with 2-himachalen-7-ol (7-HC) as the most abundant at 40%. 7-HC was isolated using column chromatography and confirmed via NMR spectroscopy and X-ray crystallography.

7-HC demonstrated potent cytotoxic activity against several human cancer cell lines including brain (SF-268, IC₅₀ 8.1 μg/mL) and colon (HT-29, IC₅₀ 10.1 μg/mL; Caco-2, IC₅₀ 9.9 μg/mL), with ovarian (Sk-OV-3, IC₅₀ > 50 μg/mL) cells being the most resistant. While HT-29 displayed resistance to cisplatin, 7-HC was 8–10-fold more potent. Co-treatment with 7-HC and cisplatin showed a significant synergistic anti-proliferative effect against SF-268, HT-29, and Caco-2 cells.

In separate work, C. libani seed extract induced erythroid differentiation and growth inhibition in K562 cells. The essential oil of C. libani was cytotoxic against drug-sensitive CCRF/CEM acute leukemia cells. The Planta Medica 2012 study (Saab et al., PMID: 23154840) further evaluated cytotoxicity of Lebanese plant-derived essential oils toward multidrug-resistant leukemia cells. C. libani was shown to possess potent antitumor effect against K562 human chronic myelogenous leukemia cells, as well as against multi-drug resistant leukemia cells. The C. libani wood oil induced erythroid differentiation at the terminal phase, which is known to stimulate the expression of fetal globin genes. Remarkably, the oil did not display cross-resistance, elevating the stature of C. libani oils as a promising source of natural active compounds for the treatment of drug-resistant leukemia and refractory tumors.

Limitation: All evidence is preclinical (cell line and animal). No human clinical trials have been reported. The therapeutic concentrations effective in cell-based systems have not been translated to pharmacokinetic or toxicological profiles in humans.

5.2 Anti-inflammatory and Analgesic Activity

Evidence base: In vitro and in vivo (rodent) studies only. No human clinical trials identified.

The Elias et al. (2019, Scientific Reports) study also evaluated anti-inflammatory effects of 7-HC in animal models. The results showed that 7-HC possesses significant anti-inflammatory activity against chronic inflammation in rats. The mechanism was investigated mechanistically: a substantial body of evidence from both in vivo and in vitro studies reported that plant-derived extracts containing sesquiterpenes, alkaloids, phenolic compounds, and flavonoids demonstrate anti-inflammatory activity by controlling levels of various inflammatory biomarkers including TNF-α, NF-κB, NO, iNOS, and COX-2. COX-2 is a key pro-inflammatory enzyme induced by LPS or cytokines, and was found to be implicated in inflammation, malignancies, and angiogenesis.

Limitation: Evidence is confined to rodent formalin-paw edema models and in vitro LPS-challenged cell systems. No dose-finding or safety data in humans exist.

5.3 Antiviral Activity (Herpes Simplex Virus Type 1)

Evidence base: In vitro only.

A study published in Phytomedicine (Loizzo MR et al., 2008; PMID: 17482448) investigated both phytochemical composition and antiviral activity. The extracts, essential oil, and identified compounds were investigated for in vitro antiviral activities against herpes simplex virus type 1 (HSV-1). Cytotoxicity was evaluated by MTT assay in Vero cells. Cones and leaves ethanol extracts exhibited an interesting activity with IC₅₀ of 0.50 and 0.66 mg/mL, respectively, at non-cytotoxic concentration.

Limitation: Single in vitro study. No follow-up antiviral trials or human data are available.

5.4 Antimicrobial Activity

Evidence base: In vitro laboratory studies only.

Multiple in vitro studies have evaluated the antimicrobial properties of C. libani essential oils and extracts against clinically relevant microorganisms. Different Lebanese conifer essential oils, harvested in Lebanon, were tested for their antimicrobial activity against different fungi and bacteria. MICs of conifer essential oils were determined against a range of bacteria and fungi responsible for skin infections using the broth microdilution technique; essential oils from C. libani showed strong activity against S. aureus (MIC of 64 μg/mL). Dermatophyte species were sensitive (MIC values 32–64 µg/mL) to essential oils from C. libani, among other Lebanese conifers.

Limitation: All antimicrobial evidence is in vitro. MIC values in cell-free systems do not directly predict clinical efficacy due to bioavailability, formulation, and delivery barriers.

5.5 Larvicidal, Acaricidal, and Insect-Repellent Activity

Evidence base: Laboratory bioassays (in vitro / ex vivo arthropod models). No human insect-repellent trials identified.

A 2023 study in Molecules (PMC free article; PMID: 38067421), by Koc et al., examined the acaricidal and repellent potential of C. libani tar: The toxic effects of tar on tick larvae were studied through larval immersion tests (LIT) and its repellent activity was evaluated using a new larval repellent activity test (LRAT). The results revealed significant acaricidal effects, with mortality rates of 77.7% and 82.2% for the Konyaalti and Kepez strains of the brown dog tick (Rhipicephalus sanguineus), respectively, in response to a 1% concentration of tar. LC₅₀ and LC₉₀ values were determined as 0.47% and 1.52% for the Kepez strain and 0.58% and 1.63% for the Konyaalti strain, respectively. When comparing the repellent effect of tar to the widely used synthetic repellent DEET, repellency rates of up to 100% were observed. This study establishes, for the first time, the larvicidal and repellent effects of C. libani tar on ticks.

A separate study found that C. libani seed oil exhibited larvicidal activity against the mosquito Culex pipiens, with LC₅₀ values ranging between 47.8 and 116 ppm. Taurus cedar tar demonstrates comparable efficacy to DEET as a repellent and nearly equivalent performance to permethrin as a larvicide.

Limitation: These are entomological laboratory bioassays; none constitute human trials for insect repellency. Formulation, safety in human topical application, and regulatory status are not established.

5.6 Antioxidant Activity

Evidence base: In vitro assays only.

The antioxidant activity of the ethanolic extracts of Cedrus libani leaves has been demonstrated, indicating the potential anti-inflammatory and analgesic properties of flavonoids and tannins. Various plant parts have a wide range of bioactivities and active phytochemicals, suggesting they might be used as a source of natural antioxidants and antimicrobials for industrial and medical applications.

Limitation: Based entirely on cell-free or cell-based antioxidant assays. No in vivo (animal or human) antioxidant studies specific to C. libani have been identified.

5.7 Blood-Related Disorders (Erythroid Differentiation)

Evidence base: In vitro cell line studies only.

Human blood-related illnesses may be treated with Cedrus libani, as suggested by preclinical research. The evidence for this comes from studies showing that C. libani wood oil and seed extracts induced terminal erythroid differentiation in K562 human chronic myelogenous leukemia cells — a differentiation-based approach to treatment rather than simple cytotoxicity. Chloroform extracts showed antiproliferative activity against K562 cells (IC₅₀ = 69.20 ± 1.69 μg/mL), while ethanol extracts evidenced a slightly higher antiproliferative activity (IC₅₀ = 40.57 ± 1.16 μg/mL) which could be mainly related to abietane diterpenoids.

Limitation: Evidence limited to K562 cell line studies; no clinical or animal in vivo hematological data identified.

6. Body Systems and Health Areas Associated with Cedrus libani

• Oncology / Hematology: Cytotoxic and antiproliferative effects in brain, colon, ovarian, and leukemia cell lines; erythroid differentiation induction in chronic myelogenous leukemia models.
• Immunology / Inflammation: COX-2, TNF-α, and NF-κB inhibition; anti-inflammatory activity in rodent edema models.
• Infectious Disease (Microbiology): In vitro activity against Staphylococcus aureus, dermatophytes, and herpes simplex virus type 1.
• Parasitology / Entomology: Acaricidal and repellent activity against ticks (R. sanguineus) and larvicidal activity against Culex pipiens mosquitoes.
• Respiratory System: Traditional use for cough, bronchitis, and respiratory infections; no modern clinical trials identified.
• Dermatology / Wound Healing: Traditional antiseptic use of resin; pharmacological properties include wound healing and cytotoxic activities.
• Oral Health: Traditional use of sap/resin for toothache.
• Analgesic: It exhibits promising analgesic and anti-inflammatory properties in preclinical models.

7. Dosage Forms and Dosages Reported in Studies

There are no standardized human dosage recommendations for Cedrus libani as a dietary supplement or therapeutic preparation. The following dosages and concentrations are reported strictly as they appear in preclinical research publications:

• Hexane heartwood oil extract (in vitro cytotoxicity, Elias et al. 2019): IC₅₀ values for 7-HC of 8.1 μg/mL (brain SF-268), 10.1 μg/mL (colon HT-29), and 9.9 μg/mL (colon Caco-2) in human cancer cell lines; ovarian Sk-OV-3 cells were most resistant (IC₅₀ > 50 μg/mL).
• Tar for tick larvae (Koc et al. 2023): A 1% concentration of tar produced mortality rates of 77.7–82.2%. LC₅₀ values were 0.47–0.58% and LC₉₀ values were 1.52–1.63% concentration in larval immersion tests.
• Seed chloroform extract (K562 leukemia cells): IC₅₀ = 69.20 ± 1.69 μg/mL.
• Seed ethanol extract (K562 leukemia cells): IC₅₀ = 40.57 ± 1.16 μg/mL.
• Cone and leaf ethanol extracts (HSV-1 antiviral, Loizzo et al. 2008): IC₅₀ of 0.50 mg/mL (cones) and 0.66 mg/mL (leaves) at non-cytotoxic concentration in Vero cells.
• Wood essential oil (C. libani, K562 anti-proliferative, Saab et al.): IC₅₀ of 23.38 μg/mL was reported for C. libani wood essential oil against K562 cells (noted in the comparative table in Saab et al. as cited in the ResearchGate record of the 2012 study).
• C. libani essential oil vs. S. aureus (Fahed et al., broth microdilution): MIC of 64 μg/mL against S. aureus.
• Dermatophytes (Fahed et al.): MIC values 32–64 µg/mL against dermatophyte species.
• Larvicidal activity vs. Culex pipiens (seed oil): LC₅₀ values ranging between 47.8 and 116 ppm.

No human oral dosage, topical dose, or standardized supplement preparation has been established or reported in the reviewed literature for Cedrus libani.

8. Safety Considerations

8.1 General Toxicological Status

More toxicological and clinical research is required to determine the applications' safety and efficacy of C. libani in treating human ailments. Most data derive from small-scale or preclinical studies, with limited standardization of dosage and formulations. Safety aspects and toxicological gaps are highlighted as essential considerations for future clinical translation; rigorous clinical trials, standardized protocols, and comprehensive toxicological evaluations are considered essential before broader therapeutic use.

8.2 Skin and Contact Sensitization

Topical use of cedarwood oil is common in cosmetics and dermatological formulations. While generally well tolerated at appropriate dilutions, reports of skin sensitization and irritation have been documented, particularly with oxidized or poor-quality oils. The high lipophilicity of sesquiterpenes may enhance dermal penetration, raising the risk of allergic reactions in sensitive individuals.

Some people may have an allergic reaction to the Cedar of Lebanon, particularly when exposed to its pollen. Contact with the resin might also cause skin irritation for sensitive individuals. Inhalation of cedar dust can cause respiratory issues for those prone to allergies.

8.3 Phytochemical Variability and Botanical Identification

The chemical composition of cedarwood oil varies markedly by botanical source. Accurate botanical identification and compositional analysis are therefore critical to minimize toxicological risk. Commercially available "cedarwood oils" may derive from entirely different botanical sources (e.g., Juniperus virginiana, Thuja plicata), some of which contain thujone — a monoterpene ketone with documented neurotoxic effects at high doses — which is not a characteristic component of Cedrus libani. This underscores the critical need for species-level authentication of any commercial preparation.

8.4 Absence of Clinical Interaction Data

No human pharmacokinetic, drug-interaction, or clinical safety studies specific to Cedrus libani preparations were identified in the reviewed peer-reviewed literature. More toxicological and clinical research is required to determine its applications' safety and efficacy in treating human ailments.

8.5 Evidence Summary

Across all areas evaluated, the evidence supporting the pharmacological use of Cedrus libani preparations in humans remains exclusively preclinical. Numerous studies on various parts of Cedrus libani shed light on its chemical composition (mostly terpenic structures) and pharmacological properties (anti-diabetic, antimicrobial, wound healing, and cytotoxic activities); however, there are undoubtedly many more discoveries to be made with further studies. A review of the ethnobotany, phytochemistry, and pharmacology of the Cedrus genus highlights cytotoxic, spasmolytic, immunomodulatory, antiallergic, anti-inflammatory, and analgesic activities — none of which have yet been substantiated by controlled human trials for C. libani specifically.

References

• Nayal R et al. (2023). Phytochemicals and bioactivities of Cedrus libani A. Rich. ResearchGate / primary journal review.
• Cedrus libani A. Rich — Chapter in Springer Nature (2022). In: Medicinal and Aromatic Plants of the World.
• Elias A et al. (2019). In Vitro and In Vivo Evaluation of the Anticancer and Anti-inflammatory Activities of 2-Himachelen-7-ol isolated from Cedrus Libani. Scientific Reports / PMC6731217.
• Elias A et al. (2019). In Vitro and In Vivo Evaluation of the Anticancer and Anti-inflammatory Activities of 2-Himachelen-7-ol isolated from Cedrus Libani. Scientific Reports (Nature).
• Loizzo MR, Saab A, Tundis R et al. (2008). Phytochemical analysis and in vitro evaluation of the biological activity against herpes simplex virus type 1 (HSV-1) of Cedrus libani A. Rich. Phytomedicine. PMID: 17482448.
• Saab AM et al. (2018). Phytochemical and pharmacological properties of essential oils from Cedrus species. Natural Product Research. PMID: 28670915.
• Saab AM, Harb F, Koenig W. (2009). Essential oil components in the leaves of Cedrus libani and Cedrus deodara. Minerva Biotechnol. ResearchGate record.
• Saab AM et al. Essential oils components in heartwood of Cedrus libani and Cedrus atlantica from Lebanon. ResearchGate.
• Raber AG et al. (2026). Cedarwood Oils: The Wood Essential Oil Compositions from Trees Known as "Cedar." Plants (MDPI). DOI: 10.3390/plants15040659.
• Koc S et al. (2023). Exploring the Larvicidal and Repellent Potential of Taurus Cedar (Cedrus libani) Tar against the Brown Dog Tick. Molecules. PMC10707419.
• Koc S et al. (2023). Exploring the Larvicidal and Repellent Potential of Taurus Cedar (Cedrus libani) Tar against the Brown Dog Tick. Molecules, 28(23), 7689.
• Saab AM et al. (2012). In vitro evaluation of the anti-proliferative activities of the wood essential oils of three Cedrus species against K562 human chronic myelogenous leukaemia cells. Planta Medica. PMID: 23154840.
• Hafizoğlu H, Holmbom B. The essential oil of Taurus cedar (Cedrus libani A. Rich): Recent results. ResearchGate.
• Cedrus Libani — ScienceDirect Topics Overview. Elsevier.
• Cedrus libani. Wikipedia (used for botanical morphology cross-reference).
• Earle CJ. Cedrus libani (cedar of Lebanon). The Gymnosperm Database.
• Cedrus libani — Smithsonian Gardens Plant Record.
• Phytochemical investigation and evaluation of antioxidant and antidiabetic activities in aqueous extracts of Cedrus atlantica. De Gruyter (Open Chemistry), 2024.
• Cedarwood essential oil (Cedrus spp.): a forgotten pharmacological resource with emerging therapeutic potential. Exploration of Drug Science, 2025.
• Insecticidal potential of Cedrus libani tar in eco-friendly control of cat flea, Ctenocephalides felis. PMC11564055.
• Elias A et al. (2019). In Vitro and In Vivo Evaluation of the Anticancer and Anti-inflammatory Activities of 2-Himachelen-7-ol isolated from Cedrus Libani. ResearchGate PDF.
• Evaluation of Cedrus atlantica Essential Oil: Chemical Composition, Anticancer Activity and Molecular Docking Studies. PMC12786621.